Concepedia

Maryann Cherubini

MC

Statistics

Publications

6

Citations

987

H-Index

6

Active since

2005

Affiliations

Monterey College of Law(Current)

Massachusetts Institute of Technology

Simons Foundation

University of Washington

Emory University

Maryann Cherubini is an author at Monterey College of Law specializing in medicine, pharmacotherapy, and neurodevelopmental disorders.

Publications per year

2005–2017

6

Publications

6

Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial

Elizabeth Berry‐Kravis, David Hessl, Barbara Rathmell et al. · Science Translational Medicine · 2012 · 325 citations · Full text

, , +17

Arbaclofen in fragile X syndrome: results of phase 3 trials

Elizabeth Berry‐Kravis, Randi J. Hagerman, Jeannie Visootsak et al. · Journal of Neurodevelopmental Disorders · 2017 · 184 citations · Full text

, , +16

Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

Jeremy Veenstra‐VanderWeele, Edwin H. Cook, Bryan H. King et al. · Neuropsychopharmacology · 2016 · 164 citations · Full text

, , +10

Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial

Daniel M. Paulson, Daniel Kennedy, Roger A. Donovick et al. · Journal of Pain · 2005 · 157 citations

, , +16

STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

Craig A. Erickson, Jeremy Veenstra‐VanderWeele, Raun D. Melmed et al. · Journal of Autism and Developmental Disorders · 2013 · 126 citations · Full text

, , +3

1–5 of 6